Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial
Vincent JL, Angus DC, Aetigas A, et al. Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. Critical Care Medicine. 2003;31(3):834–840.
This study finds that drotrecogin alfa (activated) therapy significantly improves organ function in severe sepsis.
|
This item has not yet been rated
|
 |
View article abstract
|
